This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gonçalves, M. A. F. V. Articles by de Vries, A. A. F. Search for Related Content PubMed PubMed Citation Articles by Gonçalves, M. A. F. V. Articles by de Vries, A. A. F.

 Previous Article  |  Next Article 

Journal of Virology, March 2005, p. 3146-3162, Vol. 79, No. 5
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.5.3146-3162.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Transfer of the Full-Length Dystrophin-Coding Sequence into Muscle Cells by a Dual High-Capacity Hybrid Viral Vector with Site-Specific Integration Ability

Manuel A. F. V. Gonçalves,^1* Gijsbert P. van Nierop,¹ Marloes R. Tijssen,¹ Pierre Lefesvre,² Shoshan Knaän-Shanzer,¹ Ietje van der Velde,¹ Dirk W. van Bekkum,² Dinko Valerio,¹ and Antoine A. F. de Vries¹

Gene Therapy Section, Department of Molecular Cell Biology, Leiden University Medical Center,¹ Crucell N.V., Leiden, The Netherlands²

Received 3 June 2004/ Accepted 8 October 2004

Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene, making it a potential target for gene therapy. There is, however, a scarcity of vectors that can accommodate the 14-kb DMD cDNA and permanently genetically correct muscle tissue in vivo or proliferating myogenic progenitors in vitro for use in autologous transplantation. Here, a dual high-capacity adenovirus-adeno-associated virus (hcAd/AAV) vector with two full-length human dystrophin-coding sequences flanked by AAV integration-enhancing elements is presented. These vectors are generated from input linear monomeric DNA molecules consisting of the Ad origin of replication and packaging signal followed by the recently identified AAV DNA integration efficiency element (p5IEE), the transgene(s) of interest, and the AAV inverted terminal repeat (ITR). After infection of producer cells with a helper Ad vector, the Ad DNA replication machinery, in concert with the AAV ITR-dependent dimerization, leads to the assembly of vector genomes with a tail-to-tail configuration that are efficiently amplified and packaged into Ad capsids. These dual hcAd/AAV hybrid vectors were used to express the dystrophin-coding sequence in rat cardiomyocytes in vitro and to restore dystrophin synthesis in the muscle tissues of mdx mice in vivo. Introduction into human cells of chimeric genomes, which contain a structure reminiscent of AAV proviral DNA, resulted in AAV Rep-dependent targeted DNA integration into the AAVS1 locus on chromosome 19. Dual hcAd/AAV hybrid vectors may thus be particularly useful to develop safe treatment modalities for diseases such as DMD that rely on efficient transfer and stable expression of large genes.

---

* Corresponding author. Mailing address: Gene Therapy Section, Department of Molecular Cell Biology, Leiden University Medical Center, Wassenaarseweg 72, 2333 AL Leiden, The Netherlands. Phone: 31-71-5271971. Fax: 31-71-5276180. E-mail: m.goncalves{at}lumc.nl.

---

Journal of Virology, March 2005, p. 3146-3162, Vol. 79, No. 5
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.5.3146-3162.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Goncalves, M. A.F.V., de Vries, A. A.F., Holkers, M., van de Watering, M. J.M., van der Velde, I., van Nierop, G. P., Valerio, D., Knaan-Shanzer, S. (2006). Human mesenchymal stem cells ectopically expressing full-length dystrophin can complement Duchenne muscular dystrophy myotubes by cell fusion. Hum Mol Genet 15: 213-221 [Abstract] [Full Text]